Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study - Concepedia

Concepedia

Publication | Open Access

Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study

DOI Full Paper Access

408

Citations

29

References

2006

Year

Asher Chanan‐Khan, Kena C. Miller, Laurie Musial, David Lawrence, Kenichi Takeshita, Carl W. Porter, David W. Goodrich, Zale P. Bernstein, Paul K. Wallace, David Spaner,

Journal of Clinical Oncology

Abstract

Lenalidomide is clinically active in patients with relapsed or refractory B-CLL. These findings are encouraging and warrant further investigation of this agent in the treatment of this disorder.

References

	Year	Citations

Page 1